Domnita-Valeria Rusnac

Domnita-Valeria Rusnac

Auto-generated profile, based on publicly available information

Domnita-Valeria Rusnac

Department of Pharmacology, University of Washington, Seattle, WA, 98195, U.S.A.

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Science Advances
Verified
Journal Article
Open access
MWMarkus Welcker
Markus Welcker
BWBaiyun Wang
Baiyun Wang
DRDomniţa-Valeria Rusnac
Domniţa-Valeria Rusnac
YHYasser Hussaini
Yasser Hussaini
JSJherek Swanger
Jherek Swanger
BCBruce E. Clurman
Bruce E. Clurman
C-Myc (hereafter, Myc) is a cancer driver whose abundance is regulated by the SCF Fbw7 ubiquitin ligase and proteasomal degradation. Fbw7 binds to a phosphorylated Myc degron centered at threonine 58 (T58), and mutations of Fbw7 or T58 impair Myc degradation in cancers. Here, we identify a second Fbw7 phosphodegron at Myc T244 that is required for Myc ubiquitylation and acts in concert with T58 to engage Fbw7. While Ras-dependent Myc serine 62 phosphorylation (pS62) is thought to stabilize Myc by preventing Fbw7 binding, we find instead that pS62 greatly enhances Fbw7 binding and is an integral part of a high-affinity degron. Crystallographic studies revealed that both degrons bind Fbw7 in their diphosphorylated forms and that the T244 degron is recognized via a unique mode involving Fbw7 arginine 689 (R689), a mutational hotspot in cancers. These insights have important implications for Myc-associated tumorigenesis and therapeutic strategies targeting Myc stability.

22 December 2025 in Essays in Biochemistry
Verified
Journal Article
Open access
DRDomnita-Valeria Rusnac
Domnita-Valeria Rusnac
NZNing Zheng
Ning Zheng
XXXiaowen Xie
Xiaowen Xie
Inositol hexakisphosphate (IP6) is an endogenous organic molecule present in eukaryotes. First characterized as a phosphorus-storage metabolite, it has been subsequently discovered to play a role in modulating a multitude of different biological pathways. Here, we provide a concise overview of the involvement of IP6 in the ubiquitin-proteasome system (UPS). As an allosteric regulator, a molecular glue, and a potential prosthetic group, IP6 directly impacts the activities of multiple major UPS components. We specifically highlight the structural mechanisms through which IP6 binds to individual proteins or multi-protein complexes to control their functions. The serendipitous discovery of IP6 in various protein structures raises questions about the prevalence, identity, and regulation of soluble inositol polyphosphates in the UPS, which have potential translational implications.

29 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GZGuangfeng Zhou
Guangfeng Zhou
DRDomnita-Valeria Rusnac
Domnita-Valeria Rusnac
HPHahnbeom Park
Hahnbeom Park
DCDaniele Canzani
Daniele Canzani
HNHai Minh Nguyen
Hai Minh Nguyen
FDFrank DiMaio
Frank DiMaio
Structure-based virtual screening is a key tool in early drug discovery, with growing interest in the screening of multi-billion chemical compound libraries. However, the success of virtual screening crucially depends on the accuracy of the binding pose and binding affinity predicted by computational docking. Here we developed a highly accurate structure-based virtual screen method, RosettaVS, for predicting docking poses and binding affinities. Our approach outperforms other state-of-the-art methods on a wide range of benchmarks, partially due to our ability to model receptor flexibility. We incorporate this into a new open-source artificial intelligence accelerated virtual screening platform for drug discovery. Using this platform, we screened multi-billion compound libraries against two unrelated targets, a novel ubiquitin ligase target KLHDC2 and the human voltage-gated sodium channel Na V 1.7. On both targets, we discover hits, including seven novel hits (14% hit rate) to KLHDC2 and four novel hits (44% hit rate) to Na V 1.7 with single digit micromolar binding affinities. Screening in both cases was completed in less than seven days. Finally, a high resolution X-ray crystallographic structure validates the predicted docking pose for the KLHDC2 ligand complex, demonstrating the effectiveness of our method in lead discovery.

8 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMelissa JS MacEwen
Melissa JS MacEwen
DRDomnita-Valeria Rusnac
Domnita-Valeria Rusnac
HEHenok Ermias
Henok Ermias
TLTimothy M Locke
Timothy M Locke
HGHayden E Gizinski
Hayden E Gizinski
YSYasemin Sancak
Yasemin Sancak
Activation of myosin light-chain kinase (MLCK) by calcium ions (Ca 2+ ) and calmodulin (CaM) plays an important role in numerous cellular functions including vascular smooth muscle contraction and cellular motility. Despite extensive biochemical analysis of this system, aspects of the mechanism of activation remain controversial, and competing theoretical models have been proposed for the binding of Ca 2+ and CaM to MLCK. The models are analytically solvable for an equilibrium steady state and give rise to distinct predictions that hold regardless of the numerical values assigned to parameters. These predictions form the basis of a recently proposed, multi-part experimental strategy for model discrimination. Here we implement this strategy by measuring CaM-MLCK binding using an in vitro FRET system. This system uses the CaM-binding region of smooth muscle MLCK protein to link two fluorophores to form an MLCK FRET Reporter (FR). Biochemical and biophysical experiments have established that FR can be reliably used to analyze MLCK-CaM binding. We assessed the binding of either wild-type CaM, or mutant CaM with one or more defective EF-hand domains, to FR. Interpretation of binding data in light of the mathematical models suggests a partially ordered mechanism for binding of CaM to MLCK. Complementary data collected using orthogonal approaches that directly quantify CaM-MLCK binding further supports our conclusions.

13 April 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MMMelissa MacEwen
Melissa MacEwen
DRDomnita-Valeria Rusnac
Domnita-Valeria Rusnac
HEHenok Ermias
Henok Ermias
TLTimothy Locke
Timothy Locke
HGHayden Gizinski
Hayden Gizinski
YSYasemin Sancak
Yasemin Sancak